RespirAID - Oxygen therapy for babies in low resource

Biodesign Innovation labs is developing affordable and accessible respiratory support devices for low resource setting hospitals to save babies

Respiratory illnesses is one of the main reason for deaths in developing countries and 1 in 5 deaths are due to respiratory illness. There is a need for medical intervention that aids children and adults to stabilize the patient and provide accessible healthcare solutions at a affordable cost. 

Biodesign Innovation Labs develops an affordable and accessible respiratory support device that saves babies from emergency respiratory complications such as respiratory distress syndrome, pneumonia, hypoxia, hypoxemia, perinatal asphyxia when under low resource conditions.Our solution includes ventilation assist device that is an alternative for manual ventilation and high end mechanical ventilator, low cost respiratory support device for Pneumonia and hypoxemia for children below 5 years. Our main aim is to serve the underprileveged population in the developing countries who is having issues with accessing healthcare. Children below the age of 5 years having respiratory issues has mortality and morbidity in the developing countries and according to statistics every 20 seconds, there is a death due to Pneumonia. We are trying to provide accessible and affordable healthcare solution that can save lives and impact large population in the developing countries like India.

Our solution is affordable and accessible respiratory support devices that provides effective and standardized way of providing oxygen to babies suffering from respiratory distress. This can be deployed in resource settings where there is a need for ventilators. Patients conditions usually get worens during the transit to the nearest hospitals and this causes mortality, morbidity of children below the age of 5 in developing countries. We are providing a solution that is novel way of providing oxygen to babies during respiratory distress that is affordable and accessible by anyone. 

Our technology is based on CPAP which is the integral part of our solutions .Babies under the age of 5 has high mortality rates in the developing countries due to Pneumonia. Our technology intends to provide the medical intervention that can save millions of babies' lives in the developing countries. The estimate cost below $100 USD and our core integral factors are easy to use, low skill requirement, assist control & CPAP mode. The limitations are regulatory process is time consuming and requires rigorous trials. 

Our goal is to complete our clinical trials, complete regulatory requirements and commercialize our respiratory devices globally at an affordable cost and make it accessible to everyone. In order to do that we are looking to raise $ 5 million USD to enhance our development of products, invest in R&D, grow and scale our operations in different markets. 

In the next five years, our goal is to impact one billion people globally with our accessible and affordable respiratory solutions. We are going to build strategic partnership to access different markets and help the periphery hospitals get accessible respiratory products which can be used to save babies and adults. 

We will make sure that our customer are happy. Our team will work on getting the feedback from the relevant stakeholder in the hospitals and get the first hand information and provide the feedback to the product management and engineering team to make a optimized solutions if required. We will have an affordable price for our products and the cost to provide extra service will be low post sales. We will understand the user and customer needs to make the products that our customers love. 

We are currently doing clinical trials and clinical studies.

We are estimating to serve about 10,000 people in the 12 months after regulations and trials. We will serve them via various channel such call, email, website, online meeting and direct meeting

We’re a small, international team of designers, engineers, doctors and industry experts, working on building affordable life-support systems. Our team has doctors with 13+ years of experience and engineers with great skills to build anything that is cutting edge and has huge potential for disrutive market.

Our revenue model is selling our medical devices to hospitals and through the medical device distributors and resellers. We see there is a huge need for this respiratory problem in the developing countries and we are building a innovative and novel solution that can support the lives of many people and improve the quality of life. Our strategic partnership with companies and research grants from CSR organizations and governments and other organizations can help us scale and bring a change in the developing countries and beyond that. 

I believe the MIT Community has a great potential for collaboration and building cutting edge technologies which has large impact on people. MIT Solve is trying to create sustainable solutions for future in order to make human kind get better quality of life and preserve for the future generations. Our vision and mission is to democratize healthcare with accessible and affordable healthcare solution for all. With the collaboration of MIT Solve, we believe that it will enhance and reinforce our efforts for global outreach and create impact through affordable and accessible healthcare solutions. 

One of the key barriers for our solution is the regulatory process and clinical trials. We need more funding and resources to hire right members for getting these processes done in order to commercialize our medical devices. Through MIT Solve guidance, funding and connections, we can pilot and scale our products globally. MIT Solve can help us with acceleration support and funding for us to enter the market in India and other developing countries. This will have large impact on people who can get access to healthcare irrespective of their economic background.